Skip to content

Cervical Ripening in Obese Women: Efficacy of 25 mcg Versus 50 mcg of Misoprostol

Cervical Ripening in Obese Women: a Prospective, Randomized Trial Comparing Efficacy of 25 mcg Versus 50 mcg of Misoprostol

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03748147
Enrollment
300
Registered
2018-11-20
Start date
2018-12-10
Completion date
2021-03-01
Last updated
2018-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Induction of Labor Affected Fetus / Newborn

Brief summary

This is a prospective clinical trial to determine if 50 mcg versus 25 mcg po every four hours of misoprostol has improved efficacy and similar safety in obese women undergoing cesarean section.

Detailed description

We will perform a prospective, randomized, double-blind clinical trial with parallel assignment. Obese women (delivery BMI 30 or more) who agree to participation will be randomly designated to receive either 25 mcg po q 4 hour (control) misoprosol versus 50 mcg po q 4 hours. Our primary outcome will be the rate of successful induction. Secondary outcomes will include ability to achieve a Bishop score greater than 7, time to active labor, and safety data including rate of tachysystole, non-reassuring fetal status, NICU admission.

Interventions

DRUGMisoprostol

prostaglandin e1

Sponsors

University of Cincinnati
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Masking description

Both arms will receive identical appearing drug made by the Investigational Drug Unit of the Pharmacy.

Intervention model description

Parallel design randomized trial. Two study groups: control (25 mcg) intervention (50 mcg)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Labor induction, BMI of 30 or greater, English speaking

Exclusion criteria

* Prior cesarean section, uterine tachysystole (5 contractions/ 10 minutes) on admission, Contraindication to labor induction

Design outcomes

Primary

MeasureTime frameDescription
Vaginal deliveryVariable, but within 4 daysSuccessful induction defined as a vaginal delivery following labor induction.

Secondary

MeasureTime frameDescription
Completed cervical ripening2 daysBishop score of greater than 7 (Bishop score designated per protocol based upon cervical dilation, effacement, station, consistency and position).
Specific time interval from start of induction to active labor2 daysWe will measure the interval (hours) between start of cervical ripening and active labor defined as reaching a cervical dilation of 6 cm.
Rate of tachysystole, fetal nonreassuring status, uterine rupture3 daysRate of the following as categorical variables: tachysystole (any delay in study medication administration for greater than 5 contractions/10 minute window), non-reassuring fetal status (any evaluation of the fetal tracing that leads to delays in study drug administration secondary to concerns for the fetal status), NICU admission, uterine rupture

Contacts

Primary ContactCarri R Warshak, M.D.
eaglercr@ucmail.uc.edu513-558-8448
Backup ContactDavid McKinney, M.D.
mckinndi@ucmail.uc.edu513-558-8448

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026